Full Text View
Tabular View
No Study Results Posted
Related Studies
Budesonide Versus Placebo for the Treatment of Lymphocytic Colitis
This study is ongoing, but not recruiting participants.
Study NCT00217022   Information provided by Mayo Clinic
First Received: September 14, 2005   Last Updated: March 10, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphocytic Colitis
Diarrhea
Additional conditions recognized in this trial
Colitis
Colitis, Lymphocytic
More general conditions related to this trial
Colitis, Microscopic
Colonic Diseases
Digestive System Diseases
Gastroenteritis
Gastrointestinal Diseases
Intestinal Diseases
Signs and Symptoms
Signs and Symptoms, Digestive
Interventions listed in this trial
Budesonide
More general drug interventions related to this trial
Anti-Asthmatic Agents
Anti-Inflammatory Agents
Autonomic Agents
Bronchodilator Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Mayo Clinic
AstraZeneca


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services